(Q37591246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

review article

1 reference

title

Soluble forms of RAGE in internal medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Giovanni Davi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Natale Vazzana

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Chiara Cuccurullo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

2 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

Internal and emergency medicine

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

389-401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

6 February 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11739-009-0300-1

RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11739-009-0300-1

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

21 January 2018

1 reference

12 December 2020

A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.

1 reference

12 December 2020

RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

1 reference

12 December 2020

Identification, classification, and expression of RAGE gene splice variants

1 reference

12 December 2020

Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis

1 reference

12 December 2020

The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.

1 reference

12 December 2020

Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.

1 reference

12 December 2020

Calcium-regulated intramembrane proteolysis of the RAGE receptor

1 reference

12 December 2020

The Functional -374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients

1 reference

12 December 2020

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

1 reference

12 December 2020

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

1 reference

12 December 2020

AGE-RAGE system and carcinogenesis

1 reference

12 December 2020

Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment.

1 reference

12 December 2020

Advanced glycation end products: sparking the development of diabetic vascular injury

1 reference

12 December 2020

Severity of diabetic microvascular complications is associated with a low soluble RAGE level

1 reference

12 December 2020

RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease

1 reference

12 December 2020

Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients

1 reference

12 December 2020

Soluble forms of RAGE in human diseases: clinical and therapeutical implications

1 reference

12 December 2020

RAGE polymorphisms and the heritability of insulin resistance: the Leeds family study.

1 reference

12 December 2020

Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients.

1 reference

12 December 2020

Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke.

1 reference

12 December 2020

Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.

1 reference

12 December 2020

Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease.

1 reference

12 December 2020

RAGE: a novel target for drug intervention in diabetic vascular disease

1 reference

12 December 2020

Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.

1 reference

12 December 2020

Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases

1 reference

12 December 2020

Effects of intensive glucose lowering in type 2 diabetes

1 reference

12 December 2020

Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins

1 reference

12 December 2020

Receptor for Advanced Glycation End Products (RAGE)—Soluble Form (sRAGE) and Gene Polymorphisms in Patients with Breast Cancer

1 reference

12 December 2020

Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans

1 reference

12 December 2020

Gly82Ser polymorphism of the receptor for advanced glycation end products is associated with an increased risk of gastric cancer in a Chinese population.

1 reference

12 December 2020

Platelet activation and atherothrombosis

1 reference

12 December 2020

Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population

1 reference

12 December 2020

G allele at RAGE SNP82 is associated with proinflammatory markers in obese subjects.

1 reference

12 December 2020

Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy

1 reference

12 December 2020

The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia.

1 reference

12 December 2020

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.

1 reference

12 December 2020

sRAGE and esRAGE are not associated with peripheral or autonomic neuropathy in type 2 diabetes

1 reference

12 December 2020

Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease

1 reference

12 December 2020

The biology of the receptor for advanced glycation end products and its ligands

1 reference

12 December 2020

Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control

1 reference

12 December 2020

Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery Disease

1 reference

12 December 2020

Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology

1 reference

12 December 2020

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.

1 reference

12 December 2020

Intensive glycemic control in the ACCORD and ADVANCE trials

1 reference

12 December 2020

Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease

1 reference

12 December 2020

Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis

1 reference

12 December 2020

Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis

1 reference

12 December 2020

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

12 December 2020

Soluble RAGE in type 2 diabetes: Association with oxidative stress

1 reference

12 December 2020

Diabetic vascular disease: it's all the RAGE.

1 reference

12 December 2020

A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patients

1 reference

12 December 2020

Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.

1 reference

12 December 2020

Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women

1 reference

12 December 2020

RAGE and RAGE ligands in cancer

1 reference

12 December 2020

Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.

1 reference

12 December 2020

Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospectiv

1 reference

12 December 2020

Serum endogenous secretory RAGE levels are inversely associated with carotid IMT in type 2 diabetic patients

1 reference

12 December 2020

The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease

1 reference

12 December 2020

Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury

1 reference

12 December 2020

Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.

1 reference

12 December 2020

Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients

1 reference

12 December 2020

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury

1 reference

12 December 2020

Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis

1 reference

12 December 2020

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)

1 reference

12 December 2020

10.1007/S11739-009-0300-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727582%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference